we hypothesize that gip may play a compensatory role to improve both impaired beta-cell insulin release and peripheral glucose utilization which are the recognized pathogenetic mechanisms underlying type ii diabetes mellitus .
C0021641
insulin
C0011860
type ii diabetes mellitus